Clinical Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Crohn's Disease

Clinical trial NCT07078994 · RECRUITING

Trial details

NCT number: NCT07078994
Sponsor: Biocad
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Crohn's Disease (CD)

Start date: 2025-08-14
Primary completion: 2027-05-01
Enrollment: 204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.